coronaviru
papainlik
proteas
plp
plpro
one
encod
genom
infecti
middl
east
respiratori
syndrom
mer
viru
multipl
enzymat
activ
promot
viral
infect
plpro
act
proteas
process
larg
coronaviru
polyprotein
viru
replic
plpro
also
function
deubiquitin
dub
deisgyl
deisg
enzym
remov
ubiquitin
ub
interferonstimul
gene
cellular
protein
dub
deisg
activ
implic
suppress
innat
immun
respons
howev
precis
role
activ
process
still
unclear
due
part
difficulti
separ
activ
studi
determin
first
structur
mer
plpro
complex
fulllength
human
resolut
structur
avail
structur
mer
plproub
complex
use
molecular
guid
design
plpro
mutant
lack
either
dubdeisg
activ
test
differ
plpro
mutant
proteas
dub
deisg
activitit
use
fluorescencebas
assay
result
show
select
modul
dub
activ
amino
acid
posit
mutat
plpro
posit
charg
residu
complet
impair
dubdeisg
activ
mutant
enzym
provid
new
function
tool
delin
import
dub
versu
deisg
activ
virusinfect
cell
may
serv
potenti
candid
attenu
mer
viru
vivo
modifi
vaccin
design
effort
interferonstimul
gene
antivir
ubiquitinlik
ubl
protein
rapidli
induc
type
interferon
ifn
respons
viral
infect
durfe
et
al
narasimhan
et
al
contain
two
ublfold
connect
short
interdomain
linker
hing
region
like
ubl
protein
conjug
target
protein
isopeptid
linkag
conjug
target
protein
known
isgyl
one
critic
mechan
necessari
antivir
activ
isgyl
involv
consecut
catalyt
function
three
interferoninduc
enzym
activ
enzym
conjug
enzym
follow
ligas
human
although
biochem
function
associ
isgyl
still
investig
giannakopoulo
et
al
lai
et
al
number
report
shown
conjug
target
broad
rang
virus
attempt
inhibit
viral
replic
includ
influenza
b
viru
sindbi
viru
herp
murin
herpesviru
zhao
et
al
one
model
isgyl
involv
cotransl
process
conjug
free
onto
newli
synthes
viral
protein
ribosom
order
disrupt
viral
function
durfe
et
al
help
control
antivir
effector
system
isgyl
revers
process
enzymat
deisgyl
deisg
exampl
host
cell
deisgylas
ubiquitinspecif
proteas
catalyz
remov
target
protein
cell
recent
found
human
defici
actual
increas
resist
viral
infect
vivo
contrast
observ
mice
defici
mice
suscept
viral
infect
speer
et
al
report
suggest
human
free
extracellular
may
requir
stabil
level
tempor
regul
signal
mechan
may
exist
mice
hermann
bogunov
speer
et
al
zhang
et
al
speer
et
al
suggest
isgyl
may
sequest
free
earli
infect
activ
ifn
late
infect
becom
stabil
free
dampen
ifn
respons
role
free
isgyl
viral
pathogenesi
remain
complex
especi
sinc
free
neg
regul
ifnsign
human
perng
lenschow
interestingli
virus
shown
modul
system
upregul
process
deisgyl
increas
pool
could
impact
ifn
activ
express
level
found
elev
patient
infect
chronic
hepat
c
viru
hcv
suggest
possibl
hcv
modul
hostderiv
machineri
promot
viral
infect
chen
et
al
singlestrand
rna
virus
coronavirus
cov
arterivirus
evolv
viralencod
deisgyl
mechan
counteract
host
regul
system
exampl
discov
coronaviru
papainlik
proteas
plpro
encod
deisgyl
deubiquitin
dub
catalyt
activ
addit
normal
catalyt
function
cleav
viral
polyprotein
three
site
addit
dub
deisgyl
activ
plpro
thought
contribut
suppress
innat
immun
respons
act
signal
pathway
clementz
et
al
mielech
et
al
ratia
et
al
van
kasteren
et
al
howev
precis
role
activ
antagon
innat
immun
respons
remain
unclear
due
part
difficultli
separ
activ
character
function
cell
cultur
vivo
studi
focu
plpro
merscov
highli
pathogen
betacoronaviru
still
persist
human
popul
contrast
shorterliv
sarscov
chan
et
al
sinc
initi
outbreak
case
merscov
continu
report
across
counti
largest
number
case
central
saudi
arabia
unit
arab
emir
republ
korea
approxim
report
patient
infect
merscov
succumb
fatal
respiratori
diseas
fehr
et
al
antivir
vaccin
current
avail
critic
need
understand
structur
molecular
basi
virushost
interact
facilit
design
treatment
merscov
infect
sinc
plpro
multifunct
natur
attract
target
protein
engin
studi
exampl
select
remov
plpro
dubdeisg
activ
maintain
polyprotein
cleavag
activ
one
strategi
could
potenti
use
modifi
vaccin
design
develop
attenu
coronaviru
design
differ
plpro
mutant
dub
deisg
dub
deisg
defici
would
also
advantag
function
studi
virusinfect
cell
delin
activ
contribut
viru
replic
pathogenesi
group
first
show
possibl
select
modul
sarscov
plpro
dub
andor
deisg
activ
without
affect
abil
cleav
tran
site
use
structureguid
engin
ratia
et
al
subsequ
approach
translat
merscov
plpro
use
structur
merscov
plpro
complex
ub
molecular
guid
baileyelkin
et
al
studi
introduc
mutat
plpro
domain
disrupt
dub
activ
biochem
assay
cell
cultur
proteas
activ
remain
near
wild
type
level
howev
sinc
plpro
mutant
engin
studi
test
dub
activ
still
unclear
high
level
deisg
activ
plpro
also
affect
dub
well
deisg
plpro
contribut
activ
observ
ifn
antagon
assay
baileyelkin
et
al
anoth
gap
current
knowledg
exist
understand
specif
merscov
plpro
fulllength
protein
structur
plpro
fulllength
protein
yet
determin
xray
structur
merscov
plpro
bound
ctermin
domain
human
report
lack
ntermin
domain
known
import
bind
sar
plpro
daczkowski
et
al
xray
structur
mous
complex
fulllength
mous
determin
low
sequenc
ident
plpro
addit
strictli
recogn
recognit
ub
baster
et
al
determin
xray
structur
first
viral
usp
bound
fulllength
human
protein
better
differenti
structur
basi
merscov
plpro
activ
toward
versu
ub
provid
detail
comparison
ubbound
complex
well
mutagenesi
studi
key
residu
may
shed
light
potenti
elimin
dubdeisg
activ
plpro
well
select
altern
plpro
substrat
prefer
merscov
plpro
catalyt
domain
residu
mer
viral
polyprotein
ab
miss
ubl
domain
express
plasmid
e
coli
modifi
version
studier
autoinduct
media
use
super
broth
supplement
lactos
glycerol
glucos
plu
kanamycin
describ
et
al
et
al
studier
cell
grown
l
cultur
h
inocul
ml
starter
cultur
previous
describ
clasman
et
al
cell
four
l
cultur
pellet
centrifug
min
result
pellet
two
l
cultur
distribut
two
differ
ml
falcon
tube
pellet
weigh
approxim
g
g
respect
pellet
store
purif
pellet
remov
purifi
separ
first
thaw
ice
resuspend
ml
lysi
buffer
per
g
cell
clasman
et
al
resuspens
cell
sonic
ice
protocol
lyse
shorter
min
durat
clasman
et
al
lyse
cell
clarifi
centrifug
min
supernat
pass
ml
histrap
ff
column
ge
healthcar
precharg
ni
equilibr
column
volum
cv
buffer
b
mlmin
clasman
et
al
weakli
bound
protein
elut
column
use
cv
buffer
b
bound
protein
includ
elut
column
period
min
use
linear
gradient
cv
start
buffer
b
progress
buffer
b
collect
ml
fraction
fraction
show
absorb
nm
chromatogram
analyz
sdspage
plpro
enzymat
activ
fraction
judg
pure
combin
final
pool
volum
ml
ml
respect
ntermin
octahistag
remov
dialyz
overnight
pool
l
buffer
supplement
tobacco
etch
viru
proteas
tevp
ratio
mg
tevp
mg
plpro
ratio
overnight
reaction
suffici
remov
affin
tag
tevp
reaction
kept
total
h
prepar
simultan
dialysi
precipit
observ
predominantli
contain
contamin
protein
assess
sdspage
dialyz
pool
purif
pass
separ
tandem
ml
histrap
ff
precharg
ni
column
eluat
contain
untag
flowthrough
collect
column
wash
use
cv
buffer
flowthrough
wash
sampl
combin
concentr
ml
mgml
use
amicon
centrifug
filter
unit
kda
mw
cutoff
concentr
mer
buffer
exchang
reaction
buffer
contain
mm
tri
ph
glycerol
mm
bme
use
desalt
column
ge
healthcar
untag
fresh
ie
unfrozen
unstor
use
immedi
purif
gener
fresh
complex
propargylamin
synthes
use
chitin
inteinfus
method
previous
describ
wilkinson
et
al
plasmid
express
e
coli
cell
autoinduct
h
one
liter
super
broth
cultur
inocul
ml
transform
e
coli
cell
centrifug
min
cultur
discard
supernat
harvest
cell
g
frozen
day
purif
cell
thaw
resuspend
ml
chitincolumn
buffer
mm
me
ph
mm
sodium
acet
supplement
pmsf
resuspend
cell
lyse
ice
sonic
use
branson
digit
sonif
amplitud
min
puls
delay
lyse
cell
debri
remov
centrifug
min
supernat
clarifi
lysat
save
chitin
resin
ml
ethanol
new
england
biolab
transfer
ml
frit
funnel
use
vacuum
filtrat
equilibr
ml
cold
chitincolumn
buffer
equilibr
chitin
resin
transfer
ml
beaker
combin
clarifi
lysat
ml
allow
incub
gentl
stir
min
chitin
resin
transfer
back
frit
funnel
unbound
protein
wash
use
vacuum
filtrat
ten
volum
ml
column
buffer
resin
resuspend
ml
cold
reaction
buffer
mm
me
ph
mm
sodium
acet
mm
sodium
mesna
transfer
beaker
allow
incub
overnight
gentl
stir
next
day
form
reaction
separ
resin
use
vacuum
filtrat
resin
resuspend
wash
two
ml
portion
column
buffer
recov
residu
elut
wash
combin
concentr
approxim
ml
use
amicon
centrifug
filter
unit
kda
mw
cutoff
approxim
g
propargylamin
hcl
sigmaaldrich
ad
concentr
mm
final
concentr
ml
naoh
ad
dropwis
adjust
solut
ph
gener
reaction
allow
preced
overnight
room
temperatur
final
reaction
product
centrifug
min
remov
precipit
result
supernat
concentr
approxim
ml
buffer
exchang
reaction
buffer
use
desalt
column
ge
healthcar
freshli
gener
use
immedi
gener
fresh
complex
ubpa
also
gener
similar
procedur
describ
probe
reactiv
assay
differ
ubinteincbd
express
use
e
coli
ripl
cell
protein
concentr
use
kda
mw
cutoff
amicon
devic
incub
reaction
contain
mg
mg
human
mg
plpro
mg
allow
react
overnight
reaction
buffer
amount
protein
select
base
initi
smallscal
test
reaction
sever
attempt
use
separ
complex
free
plpro
pass
reaction
ml
monoq
gl
column
ge
healthcar
regrett
free
plpro
separ
complex
sampl
assay
ubamc
activ
sampl
determin
free
plpro
mg
achiev
react
complex
addit
mg
ad
reaction
mixtur
mg
plpro
mg
reaction
mixtur
kept
h
monoq
buffer
mm
tri
ph
glycerol
mm
bme
ensur
complex
neg
charg
final
purif
step
reaction
pass
final
monoq
column
equilibr
monoq
buffer
unbound
protein
wash
cv
monoq
buffer
complex
elut
linear
gradient
monoq
buffer
b
mm
tri
ph
mm
nacl
glycerol
mm
bme
durat
min
cv
collect
ml
fraction
flow
rate
mlmin
final
pool
shown
addit
file
fig
buffer
exchang
storag
buffer
mm
tri
ph
mm
nacl
glycerol
mm
dtt
use
desalt
column
concentr
mgml
use
amicon
centrifug
filter
unit
kda
mw
cutoff
freshli
prepar
complex
use
screen
initi
crystal
condit
seri
sparsematrix
crystal
screen
solut
anatrac
midwest
center
structur
genom
mcsg
use
sit
drop
form
use
liquid
handl
robot
ttp
labtech
three
protein
concentr
mgml
mgml
mgml
dispens
three
subwel
well
sit
drop
vapor
diffus
plate
greiner
crystalquick
crystal
plate
ad
nl
purifi
complex
nl
reservoir
solut
nl
protein
drop
allow
equilibr
reservoir
solut
rigaku
ht
plate
hotel
photo
drop
record
daili
initi
crystal
hit
screen
contain
potassium
citrat
tribas
ph
wv
observ
day
initi
crystal
grew
thin
plate
hexagon
morpholog
condit
optim
use
sit
drop
format
drop
contain
purifi
complex
mgml
reservoir
optim
reagent
potassium
citrat
tribas
ph
purchas
anatrac
inc
solut
made
powder
larg
crystal
form
within
day
small
subset
condit
mani
appear
stack
plate
macroscop
twin
larg
isol
crystal
form
higher
citrat
concentr
potassium
citrat
tribas
ph
wv
harvest
obtain
crystal
data
collect
crystal
optim
macroseed
crystal
clear
drop
tray
small
microcryst
rapidli
form
macroseed
drop
subsequ
use
transfer
anoth
clear
drop
briefli
microcryst
loop
mm
loop
quickli
submerg
differ
clear
drop
transfer
microcryst
singl
isol
hexagon
crystal
form
within
min
continu
grow
size
h
high
qualiti
crystal
grown
use
techniqu
crystal
grown
initi
condit
contain
potassium
citrat
tribas
ph
wv
addit
file
fig
slightli
higher
citrat
concentr
potassium
citrat
tribas
ph
wv
crystal
harvest
use
nylon
loop
briefli
soak
cryoprotect
solut
contain
glycerol
flashcool
vial
submerg
liquid
nitrogen
vial
harbor
spine
puck
cryofreez
transport
advanc
photon
sourc
ap
argonn
nation
laboratori
anl
xray
data
collect
crystal
complex
k
use
dectri
eiger
detector
spindl
rate
beamlin
life
sciencescollabor
access
team
lscat
data
collect
three
differ
crystal
three
differ
condit
describ
index
process
scale
separ
use
minor
et
al
determin
initi
phase
complex
plpro
domain
bound
plproub
complex
pdb
access
code
use
search
model
program
phaser
mccoy
et
al
phenix
use
identifi
molecular
replac
solut
free
human
narasimhan
et
al
pdb
access
code
manual
posit
correspond
residu
electron
densiti
use
program
coot
emsley
cowtan
model
next
refin
use
ridgid
bodi
refin
program
phenixrefin
afonin
et
al
addit
round
manual
model
build
follow
coordin
bfactor
refin
perform
use
program
coot
phenixrefin
solvent
molecul
ad
toward
end
model
build
refin
ultim
complet
r
free
r
work
valu
plateau
minimum
atom
coordin
structur
factor
mer
complex
crystal
lowest
citrat
concentr
deposit
pdb
access
code
figur
gener
pymol
pymol
molecular
graphic
system
llc
seri
sitedirect
mutant
gener
use
sitedirect
mutagenesi
system
zheng
et
al
stratagen
la
jolla
ca
wildtyp
plasmid
use
templat
primer
design
synthes
use
integr
dna
technolog
idt
correct
mutat
plpro
gene
confirm
sangerbas
sequenc
purdu
genom
core
sequenc
facil
express
purif
merscov
plpro
mutant
enzym
perform
modifi
procedur
describ
wildtyp
enzym
mutant
enzym
pellet
g
two
l
cultur
harvest
twoday
purif
procedur
done
use
ni
charg
ml
histrap
ff
column
dialysi
pool
fraction
obtain
ni
hitrap
column
perform
l
buffer
h
use
ratio
tevp
plpro
order
remov
ntermin
histag
next
day
dialyz
sampl
pass
ml
ni
charg
histrap
ff
column
similar
procedur
purif
wildtyp
mer
plpro
flowthrough
well
wash
combin
concentr
instead
use
desalt
column
final
pool
buffer
exchang
storag
buffer
use
amicon
centrifug
filter
unit
kda
mw
cutoff
concentr
mgml
final
purifi
mutant
flashfrozen
liquid
nitrogen
k
store
kinet
character
remain
mutant
express
autoinduct
ml
cultur
use
super
broth
media
upon
harvest
result
pellet
g
mutant
purifi
parallel
mutant
time
pellet
resuspend
ml
lysi
buffer
cell
lyse
lower
intens
durat
min
protocol
amplitud
puls
delay
clarifi
centrifug
min
clarifi
lysat
pass
biorad
graviti
column
pack
ml
ninta
resin
thermo
fisher
scientif
equilibr
buffer
unbound
protein
wash
column
batch
wash
use
ml
buffer
ml
lower
percentag
wash
rang
buffer
b
final
mutant
plpro
elut
ml
buffer
b
wash
elut
test
absorb
nm
biotek
multivolum
plate
pool
base
presenc
hisplpro
band
kda
sdspage
gel
done
plpro
mutant
tevp
ad
pool
sampl
pool
transfer
dialysi
tube
kda
mw
cutoff
dialyz
l
buffer
h
separ
tevp
untag
plpro
mutant
dialyz
sampl
pass
graviti
column
equilibr
buffer
flowthrough
contain
untag
plpro
collect
well
ml
wash
buffer
sampl
combin
buffer
exchang
storag
buffer
use
amicon
centrifug
filter
unit
kda
mw
cutoff
protein
concentr
mgml
done
plpro
mutant
sampl
flashfrozen
liquid
nitrogen
store
import
note
wildtyp
enzym
also
purifi
procedur
compar
specif
activ
valu
obtain
protocol
sdspage
analysi
wildtyp
mutant
mer
plpro
enzym
use
kinet
experi
provid
addit
file
fig
initi
screen
assess
catalyt
activ
purifi
mutant
plpro
wildtyp
enzym
perform
singl
substrat
concentr
three
commerci
avail
fluorogen
substrat
zrlrggamc
bachem
ubamc
boston
biochemr
system
lifesensor
inc
substrat
contain
amc
fluoresc
group
cterminu
fluoresc
due
releas
amc
group
substrat
measur
describ
previous
use
biotek
synergi
multimod
micropl
reader
et
al
clasman
et
al
reaction
condit
ie
platetyp
volum
assay
previous
describ
et
al
peptid
hydrolysi
initi
plpro
final
concentr
reaction
buffer
mm
hepe
mgml
bsa
mm
dtt
ubamc
assay
reaction
initi
nm
plpro
final
concentr
except
initi
higher
enzym
concentr
final
concentr
due
lower
turnov
rate
cleav
substrat
initi
observ
purif
k
cat
ie
turnov
number
mutant
wildtyp
enzym
measur
triplic
fluorogen
substrat
substrat
concentr
rate
normal
wildtyp
rel
percentag
fulli
character
mutant
observ
differ
catalyt
rate
steadyst
kinet
paramet
merscov
plpro
wildtyp
six
mutant
determin
ubamc
substrat
concentr
vari
ubamc
reaction
initi
nm
plpro
assay
mutant
enzym
show
observ
satur
higher
substrat
concentr
initi
reaction
rate
measur
duplic
averag
rate
plot
function
substrat
concentr
data
fit
michaelismenten
equat
use
nonlinear
regress
enzym
kinet
modul
sigmaplot
version
systat
softwar
inc
kinet
paramet
k
cat
k
result
fit
data
well
calcul
valu
k
cat
k
enzym
tabul
enzym
could
satur
either
ubamc
substrat
highest
concentr
test
satur
also
observ
enzym
use
ubamc
substrat
case
initi
reaction
rate
plot
function
substrat
concentr
data
fit
line
use
linear
regress
program
graphpad
determin
appar
k
cat
k
ubpa
probe
reactiv
assay
wildtyp
mutant
mer
plpro
probe
reactiv
assay
setup
scale
pure
mer
plpro
enzym
pa
probe
reactiv
mer
plpro
wildtyp
assess
pa
probe
vari
molar
ratio
ubpa
human
dilut
storag
buffer
contain
fresh
mm
dtt
final
concentr
rang
respect
reaction
initi
mer
plpro
wildtyp
allow
react
h
room
temperatur
quench
load
buffer
mm
trishcl
ph
glycerol
sd
bromophenyl
blue
fresh
mm
dtt
reactiv
mer
plpro
wildtyp
mutant
evalu
singl
molar
ratio
plpro
either
ubpa
ratio
ratio
quench
differ
time
point
min
load
buffer
entir
reaction
load
onto
precast
sdspage
gel
biorad
protein
visual
coomassi
brilliant
blue
stain
xray
structur
determin
mer
complex
determin
previous
core
merscov
enzym
ie
without
adjac
ntermin
ubiquitinlik
domain
thermal
stabl
retain
full
kinet
activ
substrat
specif
profil
increas
abil
readili
form
crystal
diffract
high
resolut
compar
enzym
domain
clasman
et
al
therefor
use
merscov
construct
crystal
merscov
complex
gener
react
merscov
fulllength
human
protein
modifi
reactiv
propargylamid
pa
group
cterminu
pa
group
react
catalyt
cystein
form
coval
complex
readili
purifi
supplementari
data
fig
point
refer
merscov
construct
simpli
merscov
plpro
simplic
three
complet
xray
dataset
collect
crystal
merscov
complex
grown
three
differ
citrat
concentr
unexpectedli
analysi
electron
densiti
surround
znfinger
motif
complex
crystal
grown
citrat
reveal
observ
electron
densiti
zn
atom
znfinger
motif
even
though
crystal
diffract
resolut
grew
space
group
crystal
grown
two
lower
citrat
concentr
supplementari
data
fig
citrat
concentr
zn
atom
znfinger
motif
clearli
visibl
electron
densiti
suggest
higher
concentr
citrat
chelat
zn
therebi
deplet
znfinger
therefor
xray
structur
merscov
complex
grown
crystal
citrat
determin
resolut
r
work
r
free
summari
xray
data
collect
refin
statist
provid
tabl
enzym
crystal
space
group
two
ident
copi
complex
asymmetr
unit
plpro
chain
dimer
virtual
ident
rmsd
atom
residu
human
exhibit
slightli
conform
divers
rmsd
posit
interact
merscov
plpro
predominantli
central
ubiquitin
recognit
subsit
plpro
ratia
et
al
compos
residu
interfac
finger
thumb
domain
fig
watermedi
hydrophob
interact
observ
contact
region
fig
watermedi
network
predomin
form
mainchain
interact
carbonyl
group
finger
domain
plpro
carboxyl
side
chain
group
fig
sidechain
also
particip
watermedi
interact
mersplpro
van
der
waal
interact
atom
residu
also
observ
form
small
hydrophob
pocket
fig
sandwich
aliphat
chain
plpro
hydrophob
sidechain
also
interact
alkyl
group
apart
uniqu
human
prolin
tryptophan
residu
conserv
among
speci
appear
util
interact
wide
rang
deisgylas
usp
ovarian
tumor
famili
votu
suggest
region
plpro
may
critic
recognit
akutsu
et
al
baster
et
al
daczkowski
et
al
surprisingli
strong
interact
ntermin
domain
ridg
helix
plpro
fig
first
helix
thumb
domain
adjac
domain
plpro
ratia
et
al
data
refin
residu
ridg
helix
merscov
plpro
appear
within
hydrogen
bond
distanc
fig
howev
electron
densiti
associ
sidechain
especi
weak
suggest
residu
may
interact
fig
test
hypothesi
mutat
alanin
residu
well
equival
phenylalanin
residu
ubiquitin
recognit
subsit
sar
plpro
differ
observ
k
cat
valu
respons
merscov
substrat
compar
wild
type
fig
identifi
potenti
residu
merscov
plpro
dictat
substrat
specif
versu
ub
merscov
structur
superimpos
ubbound
structur
pdb
access
code
result
shown
fig
ctermin
domain
residu
ub
residu
superimpos
quit
well
rmsd
atom
plpro
structur
superimpos
rmsd
atom
fig
expect
plpro
interact
rlrgg
residu
cterminu
ub
substrat
nearli
ident
manner
util
intric
hydrogenbond
network
mainli
compos
mainchain
interact
fig
interact
describ
previous
ub
baileyelkin
et
al
one
minor
differ
orient
equival
ub
shown
fig
correspond
x
posit
lxgg
substrat
recognit
sequenc
plpro
ubbound
structur
sidechain
group
hydrogenbond
mainchain
carbonyl
found
substratebind
loop
merscov
plpro
triethylen
glycol
pge
bound
place
sidechain
fig
c
instead
undergo
interact
mainchain
carbonyl
adjac
loop
thumb
domain
plpro
helix
secondari
structur
number
base
lei
et
al
altern
conform
also
observ
structur
merscov
plpro
complex
ctermin
domain
daczkowski
et
al
therefor
observ
flexibl
arg
posit
adopt
differ
contact
plpro
ubbound
structur
guanidinium
group
plpro
form
stack
interact
guanidinium
group
equival
ub
rlrgg
motif
fig
region
howev
structur
differ
observ
residu
surround
ubbound
complex
ub
posit
allevi
chargecharg
repuls
form
favor
interact
pack
aliphat
chain
anoth
differ
observ
ubbound
structur
form
direct
hydrogenbond
interact
equival
equival
ubbound
complex
wherea
complex
form
direct
interact
fig
region
interestingli
structur
merscov
fulllength
appear
make
strong
contact
plpro
though
note
principl
electrostat
interact
structur
mersplpro
ntermin
truncat
form
fairli
weak
electrostat
interact
fulllength
structur
adopt
singl
monom
thu
presenc
ntermin
domain
fulllength
influenc
interact
ctermin
domain
plpro
anoth
common
featur
ub
bound
merscov
structur
plpro
form
van
der
waal
contact
ub
hydrophob
patch
fig
region
howev
hydrophob
patch
appear
correspond
f
c
electron
densiti
map
gray
mesh
contour
reveal
one
interact
hydrogen
bond
distanc
dot
line
observ
data
refin
weak
sidechain
densiti
pose
question
direct
interact
illustr
question
mark
extend
thu
allow
plpro
also
engag
interact
previous
note
baster
et
al
region
conserv
across
differ
speci
propos
uniqu
hydrophob
patch
differ
wellknown
hydrophob
patch
ub
commonli
util
recognit
vast
number
ubbind
protein
baster
et
al
komand
rape
observ
other
collect
support
hypothesi
hydrophob
region
may
canon
recognit
region
util
gener
deisgylas
specif
recogn
final
watermedi
contact
involv
sidechain
imidazol
also
conserv
ub
bound
merscov
plpro
structur
fig
region
although
interact
appear
extens
complex
merscov
plpro
observ
bridg
water
molecul
back
mainchain
carboxyl
glycin
residu
ub
structur
similar
watermedi
network
also
observ
sarscov
plproub
aldehyd
structur
suggest
canon
region
interven
solvent
molecul
bridg
indirect
interact
substrat
proteas
ratia
et
al
structureguid
engin
sarscov
plpro
shown
viabl
strategi
select
decoupl
sar
plpro
dub
andor
deisg
activ
maintain
abil
enzym
effici
process
polyprotein
baileyelkin
et
al
ratia
et
al
therefor
sought
use
merscov
plpro
bound
structur
previous
determin
ubbound
structur
design
set
merscov
plpro
mutant
either
dub
deisg
defici
dub
deisg
defici
ultim
goal
design
bond
residu
plpro
ub
shown
black
cyan
dash
line
respect
region
interact
plpro
show
orient
share
interact
ub
easili
accommod
charg
ub
may
favor
region
residu
plpro
form
larger
hydrophob
pocket
hydrophob
contact
share
equival
posit
region
imidazol
peptid
backbon
residu
plpro
coordin
solvent
molecul
similar
fashion
conserv
glycin
residu
less
water
cyan
sphere
molecul
observ
ubbound
structur
structur
water
red
sphere
glycerol
gol
pink
stick
molecul
observ
mutant
serv
tool
delin
function
dub
versu
deisg
activ
virusinfect
cell
potenti
gener
attenu
viru
strain
purpos
creat
liveattenu
merscov
vaccin
focus
mutagenesi
follow
merscov
plpro
residu
resid
merscov
plpro
subsit
mutant
design
base
two
approach
alaninescan
mutagenesi
complet
remov
interact
ii
insert
bulki
charg
residu
creat
steric
hindranc
ie
unfavor
van
der
waal
overlap
electrostat
repuls
disrupt
contact
addit
sought
engin
merscov
plpro
sarslik
mutat
base
equival
residu
found
sarscov
plpro
deciph
residu
contribut
sarscov
plpro
enhanc
turnov
rate
compar
merscov
plpro
differ
substrat
et
al
first
perform
initi
assess
kinet
activ
plpro
mutant
singl
substrat
concentr
test
abil
hydrolyz
three
commerci
avail
fluorogen
substrat
commonli
use
evalu
plpro
proteas
dub
deisg
activ
result
initi
assess
summar
fig
percent
rel
activ
wildtyp
enzym
mutant
exhibit
signific
alter
kinet
activ
toward
three
substrat
includ
mutant
show
reduc
peptid
hydrolysi
sever
impair
hydrolysi
dubdeisg
activ
reduct
dubdeisg
activ
peptid
hydrolysi
mutant
similar
wildtyp
surprisingli
exhibit
enhanc
hydrolysi
toward
ubamc
peptid
substrat
activ
toward
significantli
alter
compar
mutant
exhibit
moder
enhanc
ubamc
activ
final
ubamc
peptid
activ
maintain
activ
confirm
observ
trend
fulli
character
kinet
properti
mutant
kinet
paramet
k
cat
k
determin
mutant
substrat
ubamc
result
summar
tabl
along
paramet
previous
determin
mutant
daczkowski
et
al
catalyt
effici
k
cat
k
select
ratio
k
cat
k
divid
k
cat
k
ubamc
vice
versa
mutant
also
calcul
compar
wildtyp
data
observ
mutat
ridg
helix
residu
either
alanin
equival
phenylalanin
residu
sarscov
plpro
signific
effect
function
merscov
plpro
fig
result
support
predict
potenti
hydrogen
bond
observ
data
refin
plpro
unlik
import
recognit
observ
stand
stark
contrast
sarscov
plpro
two
ubiquitin
recognit
site
diub
chain
et
al
ratia
et
al
base
recognit
model
propos
ratia
et
al
sarscov
plpro
may
util
ridg
helix
directli
engag
ntermin
domain
ratia
et
al
result
indic
merscov
plpro
possess
equival
subsit
data
fig
also
suggest
residu
posit
plpro
subsit
sensit
charg
polar
size
amino
acid
introduc
posit
ad
neg
charg
aspart
residu
posit
shown
select
disrupt
recognit
mer
plpro
abil
recogn
hydrolyz
ubamc
maintain
daczkowski
et
al
aspart
like
abl
make
salt
bridg
ub
hydrophob
pocket
accommod
charg
residu
contrast
substitut
posit
charg
arginin
lysin
posit
sever
impair
activ
plpro
exampl
result
reduct
hydrolysi
nearli
reduct
ubamc
hydrolysi
baileyelkin
et
al
previous
show
complet
abolish
abil
plpro
antagon
ifn
longer
suppress
promot
cell
mimick
catalyt
dead
enzym
baileyelkin
et
al
loss
ifn
antagon
attribut
loss
dub
activ
deisg
activ
determin
base
result
loss
ifn
antagon
could
due
either
loss
either
dub
deisg
activ
gener
insert
neg
posit
charg
residu
hydrophob
pocket
found
favor
case
bind
ub
posit
charg
permit
would
introduc
chargecharg
repuls
ub
delin
observ
effect
insert
arginin
posit
simpli
due
bulk
steric
overlap
effect
also
mutat
phenylalanin
surprisingli
show
increas
k
cat
valu
ubamc
activ
similar
wildtyp
structur
would
allow
addit
interact
ub
hand
engin
conserv
mutat
ie
small
polar
serin
posit
reduc
effici
base
k
app
valu
ubamc
effici
less
affect
mutant
reach
satur
either
ubamc
loss
effici
primarili
due
increas
k
fig
tabl
select
mutant
toward
decreas
compar
wildtyp
mutant
similar
catalysi
substrat
conserv
mutat
also
restor
rlrggamc
activ
back
wildtyp
suggest
posit
plpro
critic
substrat
recognit
base
amino
acid
substitut
posit
possibl
select
modul
plpro
deisg
dub
activ
disrupt
dub
deisg
activ
simultan
structur
adjac
significantli
alter
enzymat
profil
merscov
plpro
initi
screen
fig
origin
thought
hydrophob
contact
watermedi
interact
made
signific
instead
perform
alanin
scan
sought
disrupt
merscov
plpro
activ
insert
charg
bulki
residu
posit
done
excitingli
mutat
arginin
drastic
impair
plpro
dubdeisg
activ
similar
trend
mutant
fact
observ
hydrolysi
substrat
higher
concentr
enzym
requir
nearli
approach
concentr
substrat
assay
also
exhibit
reduct
rlrggamc
activ
gener
place
bulki
charg
residu
region
plpro
affect
activ
site
function
certain
degre
also
analyz
watermedi
contact
involv
import
mutat
residu
phenylalanin
incap
hydrogen
bond
show
decreas
catalyt
effici
ubamc
interestingli
lower
k
valu
wildtyp
ubamc
versu
suggest
increas
bind
affin
substrat
also
decreas
k
cat
fig
tabl
overal
net
chang
increas
catalyt
effici
ubamc
wildtyp
enzym
observ
similar
trend
catalysi
toward
pronounc
fig
tabl
overal
plpro
catalyt
activ
sensit
posit
charg
amino
acid
posit
rather
smaller
bulki
hydrophob
residu
evalu
dubdeisg
defici
mutant
abil
react
form
coval
modif
ubpa
test
first
optim
molar
ratio
requir
complet
convers
coval
adduct
determin
use
mer
plpro
wildtyp
within
h
incub
reaction
mer
plprowildtyp
complet
modifi
ubpa
ratio
ratio
respect
fig
molar
ratio
use
analyz
reactiv
mutant
differ
time
point
wildtyp
mer
plpro
capabl
convert
fulli
complex
ubpa
within
short
min
incub
three
mutant
show
impair
reactiv
earlier
time
point
fig
c
mutant
still
show
unreact
plpro
min
incub
mutant
impair
reactiv
min
also
observ
ubpa
portion
complex
convert
fig
c
even
min
prolong
incub
unreact
plpro
still
visibl
gel
domin
band
complex
mutant
wildtyp
fig
c
singl
mutat
elicit
similar
defect
reaction
ubpa
contain
four
mutat
box
baster
et
al
data
three
mutant
impair
ub
reactiv
consist
kinet
data
mutat
may
target
dub
activ
deisg
activ
show
strike
defect
ubpa
reactiv
goal
creat
plpro
mutant
lack
dub
activ
retain
deisg
activ
focus
residu
observ
xray
structur
residu
engag
ub
substrat
mutant
partial
character
previous
shown
defici
dub
activ
test
deisg
activ
baileyelkin
et
al
addit
significantli
inhibit
plpromedi
ifnantagon
cell
quit
extent
mutant
baileyelkin
et
al
kinet
studi
present
fig
mutant
satur
ubamc
substrat
concentr
rang
test
exhibit
reduct
ubamc
catalyt
effici
compar
wildtyp
small
reduct
activ
tabl
result
suggest
observ
decreas
dub
activ
cell
like
caus
suppress
promot
rather
loss
deisg
activ
delin
reduct
dub
catalyt
activ
due
substitut
bulkier
residu
rather
charg
residu
mutat
phenylalanin
kinet
data
tabl
show
signific
effect
catalysi
support
idea
insert
posit
charg
residu
posit
detriment
dub
activ
insert
arginin
place
close
proxim
ub
guanidinium
stack
interact
plpro
ub
net
effect
charg
repuls
decreas
substrat
bind
catalysi
probe
import
plpro
involv
dub
deisg
activ
residu
mutat
alanin
exhibit
enhanc
ubamc
peptid
effici
effici
affect
tabl
surpris
observ
due
fact
arginin
like
interact
arginin
rlrgg
motif
three
substrat
possibl
remov
stack
guanidinium
group
interact
allevi
electrostat
repuls
ub
ub
easili
accommod
convers
sinc
extra
charg
equival
posit
charg
guanidinium
group
properli
balanc
neg
charg
residu
interact
water
therefor
local
environ
appear
differ
bind
substrat
sinc
sarscov
plpro
glutam
equival
posit
thought
engin
mer
sarslik
would
also
enhanc
activ
inde
exhibit
similar
trend
enhanc
ubamc
peptid
activ
activ
less
effect
exhibit
nearli
enhanc
k
ub
tabl
fig
newli
identifi
hyperact
dub
mutant
alter
select
compar
wildtyp
favor
ub
rather
fact
mutant
higher
effici
hydrolysi
toward
ubamc
compar
sarscov
plpro
wildtyp
similar
effici
hyperact
dub
mutant
previous
character
sarscov
plpro
would
also
introduc
addit
counter
ion
region
near
ub
daczkowski
et
al
result
provid
insight
chang
merscov
plpro
select
ub
without
affect
deisg
activ
altogeth
data
previou
studi
merscov
plpro
mutant
select
dub
defici
select
deisg
defici
dubdeisg
defici
identifi
fit
categori
fig
mutant
use
function
tool
probe
individu
contribut
dub
deisg
activ
merscov
replic
pathogenesi
would
interest
investig
whether
partial
complet
knockdown
dubdeisg
activ
abolish
one
activ
plpro
necessari
effici
inhibit
host
cell
antagon
attenu
mer
viru
sinc
addit
ifn
antagonist
cov
genom
addit
mutat
target
viral
protein
may
requir
provoc
question
would
whether
plpro
mutant
enhanc
dub
proteas
activ
could
potenti
enhanc
exacerb
viru
pathogenesi
sinc
mutat
exist
natur
possibl
dub
hyperact
viru
may
nonviabl
recov
use
revers
genet
system
altern
viru
may
reach
steadyst
revers
mutat
surviv
continu
replic
host
popul
studi
evalu
plpro
mutant
anim
model
need
answer
import
biolog
question
explor
potenti
use
mutant
design
develop
liveattenu
vaccin
xray
crystal
structur
merscov
design
plpro
mutant
attenu
dub
andor
deisg
activ
provid
critic
structur
function
data
new
function
tool
delin
import
dub
versu
deisg
activ
merscov
pathogenesi
replic
merscov
plpro
activ
engag
ctermin
domain
util
one
subsit
contrast
sarscov
plpro
appear
engag
nterminu
use
second
subsit
merscov
plpro
recogn
hydrophob
surfac
distinct
hydrophob
patch
ub
insert
charg
residu
plpro
contact
hydrophob
region
decreas
specif
select
disrupt
enhanc
dub
activ
plpro
accomplish
insert
posit
charg
posit
remov
charg
respect
use
mutat
probe
role
dub
activ
mer
pathogenesi
mutat
either
posit
charg
residu
complet
impair
dub
deisg
activ
make
either
mutant
use
probe
contribut
activ
dub
deisg
defici
mutant
character
studi
good
candid
investig
potenti
attenu
mer
viru
may
use
liveattenu
vaccin
design
fig
function
tool
differ
merscov
plpro
mutant
investig
date
character
select
dub
deisg
defici
dub
deisg
defici
dub
proteas
hyperact
mutat
piechart
use
repres
multifunct
activ
plpro
new
site
mutat
investig
studi
bold
plpro
mutant
first
investig
baileyelkin
ba
et
al
b
mutant
previous
character
daczkowski
cm
et
al
